Shareholders meeting

To To Date: July 09, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai-400051 Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Intimation regarding Notice of Postal Ballot Ref: Regulations 30 and 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Dear Sir/Madam, With reference to the captioned subject and pursuant to Regulations 30 and 44 of SEBI Listing Regulations, we are enclosing herewith a copy of Postal Ballot Notice (“Notice”) dated July 09, 2026, along with explanatory statement for seeking approval of the Members on Special Business as contained in the Notice through electronic voting (“remote e-voting”). In accordance with the applicable circulars issued by Ministry of Corporate Affairs (“MCA Circular”), this Notice is sent through electronic mode only to those members whose names appear in the Register of Members/ list of Beneficial Owners maintained by the Company/ Registrar and Transfer Agent (“RTA”) / Depositories, as on Friday, July 03, 2026 (“Cut-Off date”) and whose email addresses are registered with the Company/ RTA/ Depositories as on Cut-Off date. The Company has availed the services of NSDL, for facilitating remote e-voting to enable the Members to cast their votes electronically. The remote e-voting period commences on Friday, July 10, 2026 (09:00 A.M. IST) and ends on Saturday, August 08, 2026 (5.00 P.M. IST) (both days inclusive). The remote e-voting module shall, thereafter, be disabled. The said notice is also made available on the website of the Company at www.balpharma.com You are requested to kindly take the same on your records Thanking You. For Bal Pharma Ltd Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681 BAL PHARMA LIMITED CIN: L85110KA1987PLC008368 Regd Office: 21 & 22, Bommasandra Industrial Area, Bengaluru- 560099 Phone: 41379500, Fax: 22354057, E-mail: secretarial@balpharma.com, Website: www.balpharma.com POSTAL BALLOT NOTICE (Pursuant to Section 110 of the Companies Act, 2013) Dear Member(s) NOTICE is hereby given pursuant to Sections 110 and 108 read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014 ("the Rules") under the Companies Act, 2013 ("the Act ") and the General Circulars issued by the Ministry of Corporate Affairs ("MCA Circulars") and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations, 2015”), Secretarial Standards on General Meetings issued by the Institute of Company Secretaries of India and other applicable provisions, if any, for the time being in force and as amended from time to time and Secretarial Standard on General Meetings issued by the Institute of Company Secretaries of India (“SS-2”), seeking approval of the members, by way of Special Resolution, through Postal Ballot, only through electronic voting (“e-Voting”) process for the business as set out in this Postal Ballot Notice (“Notice”). The resolution to be passed together with the Statement of material facts explaining the reasons thereof pursuant to Section 102(1) of the Act 2013, is being sent to the members in electronic form to their registered e-mail IDs and annexed to the Notice for your consideration. The Company is pleased to provide the facility for voting through 'electronic means' to enable members to cast their votes through e-Voting by selecting appropriate options (instead of submitting the Postal Ballot form physically), in accordance with the provisions of the Act 2013 and Regulation 44 of the Listing Regulations, 2015. The Company, for this purpose, has engaged National Securities Depository Limited (“NSDL”), an agency authorized by the Ministry of Corporate Affairs (“MCA”), for facilitating the members to communicate their assent or dissent through ''electronic means'' in respect of the resolution. The detailed procedure for voting through “electronic means'' are given in the Notes attached herewith. The voting rights of the shareholders shall be in proportion to their shares in the paid-up equity share capital of the Company as on the cut-off date, Friday, 03rd July 2026. A person who is not a member on the cut-off date should treat this notice for information purposes only. The voting rights in respect of unclaimed shares held in Bal Pharma Ltd Unclaimed Suspense Account and Investors Education Protection Fund stand frozen in terms of Regulation 39 read with Schedule VI of the Listing Regulations, 2015 and Section 124 of the Act, 2013, respectively. Pursuant to Rule 22(5) of the Rules, the Board of Directors of the Company (“the Board”) has appointed Mr. Parameshwar Bhat, Practicing Company Secretary (M. No.11004) Bangalore, as the Scrutinizer, for conducting the postal ballot process through ‘electronic means’ in a fair and transparent manner. Members are, therefore, requested to carefully read and follow the instructions for voting through “electronic means”, from Friday, the 10th day of July, 2026, 9.00 A.M (IST) to Saturday, the 08th day of August 2026, 5.00 P.M (IST) by following the procedure as explained in the Notes herein below. The Scrutinizer will submit his report on the results of voting through electronic means to Managing Director or any one of the Directors or Key Managerial Personnel of the Company as may be authorized by the Managing Director, after completion of the scrutiny of voting by electronic means. The results will be announced by the Chairman or any one of the Directors of the Company, as duly authorized, at its registered office on or before Tuesday, the 11th day of August 2026. The results will also be intimated to the Stock Exchanges where the shares of the Company are listed and also uploaded on the website of the Company i.e. www.balpharma.com and on the website of NSDL at www.evoting.nsdl.com The last date of voting, i.e., Saturday, the 08th day of August 2026, will be taken as the date of passing of the said resolution by the members of the Company. All documents, referred to in this Notice and in the Statement of material facts referred to under Section 102(1) of the Act, 2013, are open for inspection at the Registered Office of the Company during office hours on all working days between 10.00 A.M. and 04.00 Noon up to Saturday, the 08th Day of August 2026 and shall also be available on the website of the Company viz., www.balpharma.com This Postal Ballot Notice has also been placed on the Company’s website viz, www.balpharma.com for use by the Members and the said Notice can also be accessed from website of the Stock Exchanges i.e. www.nseindia.com and www.bseindia.com and the website of NSDL at www.evoting.nsdl.com SPECIAL BUSINESS: Item No. 1 To consider the issue of 10,00,000 Warrants to the Promoter of the Company on preferential basis. To consider, and if thought fit, to pass the following resolution as Special Resolution: "RESOLVED THAT in accordance with the provisions of Sections 23, 42 and 62 (1) ( c ) read with other applicable provisions of the Companies Act, 2013 read with the Companies (Prospects and Allotment of Securities) Rules, 2014, the Companies (Share Capital and Debentures) Rules, 2014 and such other applicable Rules and Regulations made thereunder (including any amendments, modifications and/ or re-enactments thereof for the time being in force) (the “Act”), and in accordance with and subject to the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”), Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI Listing Regulations”), Securities and Exchange Boa [Showing first 8,000 characters — download PDF for full document]